Kyung Hee Lee

Title: Kyung Hee Lee: Innovator in Pharmaceutical Chemistry

Introduction

Kyung Hee Lee is a notable inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on furancarbonylguanidine derivatives. His research focuses on developing compounds that can aid in the treatment of ischemic heart diseases.

Latest Patents

Kyung Hee Lee holds a patent for "Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them." This invention relates to the preparation method of furancarbonylguanidine derivatives, which have been shown to inhibit NHE-1 (sodium-hydrogen exchanger isoform 1). The protective effects of these derivatives on myocardial cells indicate their potential for preventing and treating conditions such as myocardial infarction, arrhythmia, and angina pectoris.

Career Highlights

Throughout his career, Kyung Hee Lee has worked with esteemed organizations, including the Korea Research Institute of Chemical Technology and Yuyu, Inc. His work has been instrumental in advancing the understanding of heart protection mechanisms and developing therapeutic agents for heart diseases.

Collaborations

Kyung Hee Lee has collaborated with notable colleagues, including Kyu Yang Yi and Sun Kyung Lee, who have contributed to his research endeavors. Their combined expertise has furthered the development of innovative pharmaceutical solutions.

Conclusion

Kyung Hee Lee's contributions to pharmaceutical chemistry, particularly through his patent on furancarbonylguanidine derivatives, highlight his role as an innovator in the field. His work promises to have a lasting impact on the treatment of ischemic heart diseases.